News & Updates

Neurosurgery performed 2–4 hours after presenting to the emergency department (ED) seems to result in better survival outcomes in patients with spontaneous haemorrhagic stroke, reports a recent study.

Treatment with ravulizumab leads to rapid and sustained reductions in myasthenia gravis (MG) symptoms, according to the CHAMPION study presented at AAN 2022.

Long-term use of cannabis tends to result in cognitive deficits and smaller hippocampal volume in midlife, according to a recent study.

Most patients with psychiatric illness sustain physical pain, and they perceive pain differently, according to a Singapore study.

Lower-sodium oxybate – a new oxybate treatment with 92-percent less sodium than sodium oxybate – continued to demonstrate its potential in improving function, productivity, and sleepiness in individuals with idiopathic hypersomnia, according to data presented at AAN 2022.

The cardioprotective effects of exercise are nearly twice as large in people with anxiety and depression than in those without, suggests a new study presented at ACC.22.

Implantation with a motor neuroprosthesis, an endovascular brain-computer interface, appears to be safe in amyotrophic lateral sclerosis (ALS) patients with paralysis and helps them operate a computer for daily tasks, according to a study presented at the American Academy of Neurology’s (AAN) Annual Meeting.